MicroRNA sequence polymorphisms and the risk of different types of cancer

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Hu, Ye ^a,b,c   Yu, Chen Yang ^a,b,c   Wang, Ji Lin ^a,b,c   Guan, Jian ^d   Chen, Hao Yan ^a,b,c   Fang, Jing Yuan ^a,b,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BEIJING HOSPITAL   (China)

^c School of Medicine   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

CASE CONTROL STUDY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; META ANALYSIS; NEOPLASM; PUBLISHING; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; NEOPLASMS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK;

EID: 84892616707     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03648     Document Type: Article

References (59)

1. Lagos-Quintana, M., Rauhut, R., Lendeckel, W. & Tuschl, T. Identification of novel genes coding for small expressed RNAs. Science. 294, 853-8 (2001). (Pubitemid 33032103)
2. Ambros, V.MicroRNA pathwaysinflies and worms: growth, death, fat, stress, and timing. Cell. 113, 673-6 (2003).
3. Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature. 435, 834-8 (2005). (Pubitemid 40839735)
4. Ryan, B. M., Robles, A. I. & Harris, C. C. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer. 10, 389-402 (2010).
5. Ma, Y. et al. Candidate microRNA biomarkers in human colorectalcancer: systematicreview profiling studies andexperimental validation. Int J Cancer. 130, 2077-87 (2012).
6. Hinds, D. A. et al. Whole-genome patterns of common DNA variation in three human populations. Science. 307, 1072-9 (2005). (Pubitemid 40262106)
7. Duan, R., Pak, C. & Jin, P. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet. 16, 1124-31 (2007). (Pubitemid 47062732)
8. Solovieff, N., Cotsapas, C., Lee, P. H., Purcell, S. M. & Smoller, J. W. Pleiotropy in complex traits: challenges and strategies. Nat Rev Genet. 14, 483-95, doi: 10.1038/nrg3461 (2013).
9. Xu, T. et al. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis. 29, 2126-31 (2008).
10. Jazdzewski, K. et al. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA. 105, 7269-74 (2008). (Pubitemid 351754467)
11. He, B. et al. The association between four genetic variants in microRNAs (rs11614913, rs2910164, rs3746444, rs2292832) and cancer risk: evidence from published studies. PLoS One. 7, e49032 (2012).
12. Shen, J. et al. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis. 29, 1963-6 (2008).
13. Kogo, R., Mimori, K., Tanaka, F., Komune, S. & Mori, M. Clinical significance of miR-146a in gastric cancer cases. Clin Cancer Res. 17, 4277-84 (2011).
14. Xu, W. et al. Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis. PLoS One. 6, e20471 (2011).
15. Wang, M. et al. Genetic variants in miRNAs predict bladder cancer risk and recurrence. Cancer Res. 72, 6173-82 (2012).
16. Kasashima, K., Nakamura, Y. &Kozu, T. Altered expression profiles of microRNAs during TPA-induced differentiation of HL-60 cells. Biochem Biophys Res Commun. 322, 403-410 (2004). (Pubitemid 39490318)
17. Guled, M. et al. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma-A miRNA microarray analysis. Genes Chromosomes Cancer. 48, 615-623 (2009).
18. Hui, A.B. et al. Comprehensive microRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res. 16, 1129-1139 (2010).
19. Farazi, T. A. et al. MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res. 71, 4443-4453 (2011).
20. Xu, B. et al. A functional polymorphism in Pre-miR-146a gene is associated with prostate cancer risk and mature miR-146a expression in vivo. Prostate. 70, 467-472 (2010).
21. Hu, Y. et al. Two common SNPs in pri-miR-125a alter the mature miRNA expression and associate with recurrent pregnancy loss in a Han-Chinese population. RNA Biol. 8, 861-72 (2011).
22. Akkiz, H., Bayram, S., Bekar, A., Akgöllü, E. & Ulger, Y. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study. J Viral Hepat. 18, e399-407 (2011).
23. Ye, Y. et al. Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prev Res. 1, 460-9 (2008).
24. Farazi, T. A. et al. MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res. 71, 4443-53 (2011).
25. Smith, R. A. et al. A genetic variant located in miR-423 is associated with reduced breast cancer risk. Cancer Genomics Proteomics. 9, 115-8 (2012).
26. Kontorovich, T., Levy, A., Korostishevsky, M., Nir, U. & Friedman, E. Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk women. Int J Cancer. 127, 589-97 (2009).
27. Zhang, M. W. et al. Associations of lifestyle-related factors, hsa-miR-149 and hsa-miR-605 gene polymorphisms with gastrointestinal cancer risk. Mol Carcinog. 51, E21-31 (2012).
28. Xiao, J., Lin, H., Luo, X. & Wang, Z. MiR-605 joins p53 network to form a p53: miR-605:Mdm2 positive feedback loop in response to stress. EMBO J. 30, 524-32 (2011).
29. Zhu, L., Wang, Z., Fan, Q., Wang, R. &Sun, Y. MicroRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS. Oncol Rep. 31, 280-6 (2013).
30. Chen, Z. et al. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/b-catenin pathway in hepatocellular carcinoma cells. Cell Signal. 25, 2693-701 (2013).
31. Yang, R. et al. A genetic variant inthe pre-miR-27a oncogene is associated witha reduced familial breast cancer risk. Breast Cancer Res Treat. 121, 693-702 (2010).
32. Zhang, M. et al. Associations ofmiRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population. Eur J Cancer Care. 2, 274-80 (2012).
33. Hezova, R. et al. Evaluation of SNPsinmiR-196-a2, miR-27a and miR-146a asrisk factors of colorectal cancer. World J Gastroenterol. 18, 2827-31 (2012).
34. Zhan, J. F. et al. A functional variant in microRNA-196a2 is associated with susceptibility of colorectal cancer in a Chinese population. Arch Med Res. 42, 144-8 (2011).
35. Li, X. D., Li, Z. G., Song, X. X. & Liu, C. F. A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis. Pathology. 42, 669-73 (2010).
36. Wang, F. et al. A genetic variant in microRNA-196a2 is associated with increased cancer risk: a meta-analysis. Mol Biol Rep. 39, 269-75 (2012).
37. Chu, H. et al. Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case-control studies. PLoS One. 6, e18108 (2011).
38. Tian, T. et al. A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol Biomarkers Prev. 18, 1183-7 (2009).
39. Doghman, M. et al. Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors. Cancer Res. 70, 4666-75 (2010).
40. Nagaraja, A. K. et al. A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. Mol Endocrinol. 24, 447-63 (2010).
41. Zheng, Y. S. et al. MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia. Oncogene. 31, 80-92 (2012).
42. Ryan, B. M. et al. Rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancer. PLoS One. 7, e36306 (2012).
43. Hu, Z. et al. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat. 30, 79-84 (2009).
44. Vinci, S. et al. Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. Clin Chem Lab Med. 49, 2073-80 (2011).
45. Zhang, M. W. et al. Associations of lifestyle-related factors, hsa-miR-149 and hsa-miR-605 gene polymorphisms with gastrointestinal cancer risk. Mol Carcinog. 51, E21-31 (2012).
46. Catucci, I. et al. Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum Mutat. 31, E1052-7 (2010).
47. Okubo, M. et al. Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter. 15, 524-31 (2010).
48. Okubo, M. et al. Investigative role of pre-microRNAs in bladder cancer patients: a case-control study in North India. DNA Cell Biol. 30, 401-6 (2011).
49. Rothman, N. et al. A multi-stage genome-wide association study of bladder cancer identifies multiply susceptibility loci. Nat Genet. 42, 978-84 (2010).
50. Hunter, D. J. et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet. 39, 870-4 (2007). (Pubitemid 47014500)
51. Landi, M. T. et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet. 85, 679-91 (2009).
52. Petersen, G. M. et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet. 42, 224-8 (2010).
53. Yeager, M. et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet. 39, 645-9 (2007). (Pubitemid 46676108)
54. Purdue, M. P. et al. Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet. 43, 60-5 (2011).
55. Abnet, C. C. et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet. 42, 764-7 (2010).
56. Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 38, 904-909 (2006). (Pubitemid 44141658)
57. Li, J. et al. Identification of high-quality cancer prognostic markers and metastasis network modules. Nat Commun. 1, 1-8; doi:10.1038/ncomms1033 (2010).
58. Evangelou, E. & Ioannidis, J. P. Meta-analysis methods for genome-wide association studies and beyond. Nat Rev Genet. 14, 379-89 (2013).
59. Cotsapas, C. et al. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet. 7, e1002254 (2011).